RGS2 and ovarian cancer: Taken together, these data show that RGS2, RGS10, and RGS17 transcripts are commonly downregulated in acquired chemoresistance in three distinct ovarian cancer cell lines resistant to three distinct chemotherapeutics, while RGS5 was down-regulated in two of the models.